Gujarat Themis Biosyn Ltd.
•₹ 381.23.24%
2026-08-21
PROS
- Company has a healthy return on capital (ROCE) of 44.8%
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.17x)
- Company comfortably covers its interest (181.0x coverage)
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Stock is trading at 12.3x its book value
- Operating margins have contracted to 45.7% from 54.1%
- Debtor days have increased from 48 to 71
- Expensive relative to growth - PEG of 16.6
- Growth is decelerating - 3Y profit CAGR (3.8%) trails the 5Y trend (15.6%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | GUJTHEM | 375.35 | 0.00 | 4046.97 | 0.18 | 110.67 | — | 437.90 | — | 27.48 | 47.49 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50 | 40 | 39 | 42 | 39 | 35 | 40 | 38 | 36 | 42 | 43 | 44 | 44 | |
| 26 | 23 | 21 | 21 | 20 | 19 | 21 | 22 | 22 | 21 | 22 | 25 | 29 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 4 | 4 | 4 |
| 24 | 17 | 18 | 21 | 18 | 14 | 17 | 16 | 12 | 19 | 17 | 14 | 15 | |
| Tax % | 25.58% | 25.70% | 26.46% | 24.15% | 25.87% | 25.58% | 25.46% | 25.42% | 25.25% | 23.99% | 26.14% | 24.06% | 27.03% |
| Net Profit | 18 | 13 | 13 | 16 | 13 | 11 | 13 | 12 | 9 | 14 | 12 | 11 | 11 |
| 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 50
- 26
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 24
- Tax %
- 25.58%
- Net Profit
- 18
- 2
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 40
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 17
- Tax %
- 25.70%
- Net Profit
- 13
- 1
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 39
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 18
- Tax %
- 26.46%
- Net Profit
- 13
- 1
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 42
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 21
- Tax %
- 24.15%
- Net Profit
- 16
- 1
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 39
- 20
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 18
- Tax %
- 25.87%
- Net Profit
- 13
- 1
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 7
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 35
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 14
- Tax %
- 25.58%
- Net Profit
- 11
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 40
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 2
- 17
- Tax %
- 25.46%
- Net Profit
- 13
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 38
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 16
- Tax %
- 25.42%
- Net Profit
- 12
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 36
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 2
- 12
- Tax %
- 25.25%
- Net Profit
- 9
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 42
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 19
- Tax %
- 23.99%
- Net Profit
- 14
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 43
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 4
- 17
- Tax %
- 26.14%
- Net Profit
- 12
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 44
- 25
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- 14
- Tax %
- 24.06%
- Net Profit
- 11
- 1
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 44
- 29
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 15
- Tax %
- 27.03%
- Net Profit
- 11
- 0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 33 | 36 | 39 | 41 | 85 | 91 | 115 | 148 | 170 | 151 | 174 | |
| 27 | 30 | 33 | 34 | 53 | 50 | 57 | 75 | 91 | 82 | 97 | |
| Operating Profit | 6 | 6 | 6 | 10 | 34 | 44 | 62 | 80 | 83 | 71 | — |
| OPM % | 19 | 18 | 17 | 23 | 39 | 48 | 54 | 54 | 49 | 47 | — |
| Other Income | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 7 | 4 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 5 | 15 |
| 5 | 5 | 5 | 8 | 31 | 41 | 59 | 77 | 79 | 66 | 65 | |
| Tax % | 0 | 10 | 20 | 22 | 24 | 26 | 26 | 25 | 25 | 26 | 25 |
| Net Profit | 5 | 4 | 4 | 6 | 24 | 30 | 44 | 58 | 59 | 49 | 49 |
| EPS | 3 | 3 | 3 | 4 | 16 | 21 | 30 | 8 | 8 | 4 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 10 | 0 | 37 | 14 | 12 | 15 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 5 | 5 | 4 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 5 | 5 | 4 | — |
Mar 2016
- 33
- 27
- Operating Profit
- 6
- OPM %
- 19
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 5
- Tax %
- 0
- Net Profit
- 5
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 36
- 30
- Operating Profit
- 6
- OPM %
- 18
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 5
- Tax %
- 10
- Net Profit
- 4
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2018
- 39
- 33
- Operating Profit
- 6
- OPM %
- 17
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 5
- Tax %
- 20
- Net Profit
- 4
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2019
- 41
- 34
- Operating Profit
- 10
- OPM %
- 23
- Other Income
- 2
- Interest
- 0
- Depreciation
- 1
- 8
- Tax %
- 22
- Net Profit
- 6
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 85
- 53
- Operating Profit
- 34
- OPM %
- 39
- Other Income
- 2
- Interest
- 1
- Depreciation
- 1
- 31
- Tax %
- 24
- Net Profit
- 24
- EPS
- 16
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2021
- 91
- 50
- Operating Profit
- 44
- OPM %
- 48
- Other Income
- 3
- Interest
- 1
- Depreciation
- 2
- 41
- Tax %
- 26
- Net Profit
- 30
- EPS
- 21
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2022
- 115
- 57
- Operating Profit
- 62
- OPM %
- 54
- Other Income
- 4
- Interest
- 1
- Depreciation
- 2
- 59
- Tax %
- 26
- Net Profit
- 44
- EPS
- 30
- Dividend Payout %
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2023
- 148
- 75
- Operating Profit
- 80
- OPM %
- 54
- Other Income
- 7
- Interest
- 0
- Depreciation
- 3
- 77
- Tax %
- 25
- Net Profit
- 58
- EPS
- 8
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 170
- 91
- Operating Profit
- 83
- OPM %
- 49
- Other Income
- 4
- Interest
- 0
- Depreciation
- 4
- 79
- Tax %
- 25
- Net Profit
- 59
- EPS
- 8
- Dividend Payout %
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 151
- 82
- Operating Profit
- 71
- OPM %
- 47
- Other Income
- 2
- Interest
- 0
- Depreciation
- 5
- 66
- Tax %
- 26
- Net Profit
- 49
- EPS
- 4
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
TTM
- 174
- 97
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 5
- Depreciation
- 15
- 65
- Tax %
- 25
- Net Profit
- 49
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 17%
- 5 Years:
- 12%
- 3 Years:
- 10%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 27%
- 5 Years:
- 16%
- 3 Years:
- 4%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -4%
RETURN ON EQUITY
- 10 Years:
- 74%
- 5 Years:
- 41%
- 3 Years:
- 34%
- Last Year:
- 22%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 11 |
| -3 | 1 | 5 | 11 | 35 | 63 | 96 | 142 | 194 | 237 | |
| 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 6 | 7 | 6 | 6 | 7 | 4 | 7 | 10 | 10 | 15 |
| 5 | 4 | 2 | 9 | 21 | 25 | 27 | 28 | 30 | 55 | |
| Total Liabilities | 15 | 21 | 20 | 33 | 71 | 98 | 137 | 187 | 241 | 318 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 9 | 11 | 11 | 15 | 17 | 19 | 19 | 33 | 38 | 41 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 0 | 2 | 13 | 21 | 91 | 184 |
| 0 | 1 | 0 | 0 | 6 | 6 | 12 | 15 | 3 | 5 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 31 | |
| Cash & Bank | 0 | 0 | 4 | 2 | 2 | 28 | 12 | 9 | 8 | 13 |
| 5 | 10 | 5 | 15 | 45 | 44 | 81 | 110 | 73 | 43 | |
| Total Assets | 15 | 21 | 20 | 33 | 71 | 98 | 137 | 187 | 241 | 318 |
| Total Debt | 3 | 4 | 1 | 6 | 8 | 3 | 0 | 0 | 0 | 30 |
| Net Working Capital | -6 | -4 | -0 | -5 | 12 | 47 | 61 | 46 | 31 | 31 |
| Contingent Liabilities | 9 | 9 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Book Value per Share | 2.65 | 5.65 | 8.34 | 12.75 | 29.04 | 48.14 | 71.11 | 102.66 | 27.72 | 22.79 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 1.00 | 1.00 |
| Total Debt | 3 | 4 | 1 | 6 | 8 | 3 | 0 | 0 | 0 | 30 |
| Net Working Capital | -6 | -4 | -0 | -5 | 12 | 47 | 61 | 46 | 31 | 31 |
| Contingent Liabilities | 9 | 9 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Book Value per Share | 2.65 | 5.65 | 8.34 | 12.75 | 29.04 | 48.14 | 71.11 | 102.66 | 27.72 | 22.79 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 1.00 | 1.00 |
Mar 2016
- Equity Capital
- 7
- -3
- 0
- Trade Payables
- 6
- 5
- Total Liabilities
- 15
- 9
- Capital Work in Progress
- 0
- 0
- 0
- Cash & Bank
- 0
- 5
- Total Assets
- 15
- Total Debt
- 3
- Net Working Capital
- -6
- Contingent Liabilities
- 9
- Book Value per Share
- 2.65
- Face Value
- 5.00
- Total Debt
- 3
- Net Working Capital
- -6
- Contingent Liabilities
- 9
- Book Value per Share
- 2.65
- Face Value
- 5.00
Mar 2017
- Equity Capital
- 7
- 1
- 2
- Trade Payables
- 7
- 4
- Total Liabilities
- 21
- 11
- Capital Work in Progress
- 0
- 1
- 0
- Cash & Bank
- 0
- 10
- Total Assets
- 21
- Total Debt
- 4
- Net Working Capital
- -4
- Contingent Liabilities
- 9
- Book Value per Share
- 5.65
- Face Value
- 5.00
- Total Debt
- 4
- Net Working Capital
- -4
- Contingent Liabilities
- 9
- Book Value per Share
- 5.65
- Face Value
- 5.00
Mar 2018
- Equity Capital
- 7
- 5
- 0
- Trade Payables
- 6
- 2
- Total Liabilities
- 20
- 11
- Capital Work in Progress
- 0
- 0
- 0
- Cash & Bank
- 4
- 5
- Total Assets
- 20
- Total Debt
- 1
- Net Working Capital
- -0
- Contingent Liabilities
- 3
- Book Value per Share
- 8.34
- Face Value
- 5.00
- Total Debt
- 1
- Net Working Capital
- -0
- Contingent Liabilities
- 3
- Book Value per Share
- 8.34
- Face Value
- 5.00
Mar 2019
- Equity Capital
- 7
- 11
- 0
- Trade Payables
- 6
- 9
- Total Liabilities
- 33
- 15
- Capital Work in Progress
- 1
- 0
- 0
- Cash & Bank
- 2
- 15
- Total Assets
- 33
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 4
- Book Value per Share
- 12.75
- Face Value
- 5.00
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 4
- Book Value per Share
- 12.75
- Face Value
- 5.00
Mar 2020
- Equity Capital
- 7
- 35
- 0
- Trade Payables
- 7
- 21
- Total Liabilities
- 71
- 17
- Capital Work in Progress
- 0
- 6
- 0
- Cash & Bank
- 2
- 45
- Total Assets
- 71
- Total Debt
- 8
- Net Working Capital
- 12
- Contingent Liabilities
- 4
- Book Value per Share
- 29.04
- Face Value
- 5.00
- Total Debt
- 8
- Net Working Capital
- 12
- Contingent Liabilities
- 4
- Book Value per Share
- 29.04
- Face Value
- 5.00
Mar 2021
- Equity Capital
- 7
- 63
- 0
- Trade Payables
- 4
- 25
- Total Liabilities
- 98
- 19
- Capital Work in Progress
- 2
- 6
- 0
- Cash & Bank
- 28
- 44
- Total Assets
- 98
- Total Debt
- 3
- Net Working Capital
- 47
- Contingent Liabilities
- 4
- Book Value per Share
- 48.14
- Face Value
- 5.00
- Total Debt
- 3
- Net Working Capital
- 47
- Contingent Liabilities
- 4
- Book Value per Share
- 48.14
- Face Value
- 5.00
Mar 2022
- Equity Capital
- 7
- 96
- 0
- Trade Payables
- 7
- 27
- Total Liabilities
- 137
- 19
- Capital Work in Progress
- 13
- 12
- 0
- Cash & Bank
- 12
- 81
- Total Assets
- 137
- Total Debt
- 0
- Net Working Capital
- 61
- Contingent Liabilities
- 4
- Book Value per Share
- 71.11
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 61
- Contingent Liabilities
- 4
- Book Value per Share
- 71.11
- Face Value
- 5.00
Mar 2023
- Equity Capital
- 7
- 142
- 0
- Trade Payables
- 10
- 28
- Total Liabilities
- 187
- 33
- Capital Work in Progress
- 21
- 15
- 0
- Cash & Bank
- 9
- 110
- Total Assets
- 187
- Total Debt
- 0
- Net Working Capital
- 46
- Contingent Liabilities
- 4
- Book Value per Share
- 102.66
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 46
- Contingent Liabilities
- 4
- Book Value per Share
- 102.66
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 7
- 194
- 0
- Trade Payables
- 10
- 30
- Total Liabilities
- 241
- 38
- Capital Work in Progress
- 91
- 3
- 27
- Cash & Bank
- 8
- 73
- Total Assets
- 241
- Total Debt
- 0
- Net Working Capital
- 31
- Contingent Liabilities
- 4
- Book Value per Share
- 27.72
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 31
- Contingent Liabilities
- 4
- Book Value per Share
- 27.72
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 11
- 237
- 0
- Trade Payables
- 15
- 55
- Total Liabilities
- 318
- 41
- Capital Work in Progress
- 184
- 5
- 31
- Cash & Bank
- 13
- 43
- Total Assets
- 318
- Total Debt
- 30
- Net Working Capital
- 31
- Contingent Liabilities
- 5
- Book Value per Share
- 22.79
- Face Value
- 1.00
- Total Debt
- 30
- Net Working Capital
- 31
- Contingent Liabilities
- 5
- Book Value per Share
- 22.79
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 3 | 6 | 1 | 1 | 11 | 40 | 39 | 64 | 91 | |
| Cash from Investing | -1 | -3 | -1 | -6 | -3 | -2 | -30 | -20 | -55 | -112 |
| Cash from Financing | -3 | -0 | -4 | 5 | 2 | -5 | -14 | -13 | -9 | 26 |
| -0 | 0 | 1 | 0 | -0 | 3 | -4 | 6 | 0 | 5 | |
| Free Cash Flow | 3 | 3 | 5 | -5 | -3 | 5 | 27 | 16 | -14 | -10 |
| OCF / Net Profit | 0.85 | 0.64 | 1.44 | 0.11 | 0.03 | 0.35 | 0.92 | 0.68 | 1.09 | 1.87 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 2 | 5 | 29 | 40 | 32 | 24 |
| OCF / Net Profit | 0.85 | 0.64 | 1.44 | 0.11 | 0.03 | 0.35 | 0.92 | 0.68 | 1.09 | 1.87 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 2 | 5 | 29 | 40 | 32 | 24 |
Mar 2016
- 4
- Cash from Investing
- -1
- Cash from Financing
- -3
- -0
- Free Cash Flow
- 3
- OCF / Net Profit
- 0.85
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.85
- Cumulative 5-Year FCF
- 0
Mar 2017
- 3
- Cash from Investing
- -3
- Cash from Financing
- -0
- 0
- Free Cash Flow
- 3
- OCF / Net Profit
- 0.64
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.64
- Cumulative 5-Year FCF
- 0
Mar 2018
- 6
- Cash from Investing
- -1
- Cash from Financing
- -4
- 1
- Free Cash Flow
- 5
- OCF / Net Profit
- 1.44
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.44
- Cumulative 5-Year FCF
- 0
Mar 2019
- 1
- Cash from Investing
- -6
- Cash from Financing
- 5
- 0
- Free Cash Flow
- -5
- OCF / Net Profit
- 0.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.11
- Cumulative 5-Year FCF
- 0
Mar 2020
- 1
- Cash from Investing
- -3
- Cash from Financing
- 2
- -0
- Free Cash Flow
- -3
- OCF / Net Profit
- 0.03
- Cumulative 5-Year FCF
- 2
- OCF / Net Profit
- 0.03
- Cumulative 5-Year FCF
- 2
Mar 2021
- 11
- Cash from Investing
- -2
- Cash from Financing
- -5
- 3
- Free Cash Flow
- 5
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- 5
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- 5
Mar 2022
- 40
- Cash from Investing
- -30
- Cash from Financing
- -14
- -4
- Free Cash Flow
- 27
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 29
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 29
Mar 2023
- 39
- Cash from Investing
- -20
- Cash from Financing
- -13
- 6
- Free Cash Flow
- 16
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 40
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 40
Mar 2024
- 64
- Cash from Investing
- -55
- Cash from Financing
- -9
- 0
- Free Cash Flow
- -14
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 32
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 32
Mar 2025
- 91
- Cash from Investing
- -112
- Cash from Financing
- 26
- 5
- Free Cash Flow
- -10
- OCF / Net Profit
- 1.87
- Cumulative 5-Year FCF
- 24
- OCF / Net Profit
- 1.87
- Cumulative 5-Year FCF
- 24
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 3.19 | 3.01 | 2.66 | 4.41 | 16.30 | 20.77 | 30.03 | 39.90 | 8.14 | 4.48 |
| Book Value (₹) | 2.65 | 5.65 | 8.34 | 12.75 | 29.04 | 48.14 | 71.11 | 102.66 | 27.72 | 22.79 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.65 | 0.00 | 11.00 | 5.40 | 1.00 | 0.67 |
| Cash EPS (₹) | 0.53 | 0.50 | 0.46 | 0.70 | 2.30 | 2.93 | 4.21 | 5.56 | 5.75 | 4.97 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 19.02% | 17.97% | 16.51% | 23.33% | 39.40% | 48.14% | 54.06% | 54.06% | 46.36% | 45.65% |
| Net Margin % | 14.19% | 12.26% | 9.97% | 15.61% | 27.81% | 33.32% | 37.98% | 39.07% | 34.84% | 32.34% |
| ROE % | 302.71% | 72.63% | 38.06% | 41.85% | 77.99% | 53.82% | 50.35% | 45.92% | 33.76% | 21.69% |
| ROCE % | 80.38% | 54.67% | 42.22% | 44.88% | 85.96% | 67.89% | 67.91% | 61.51% | 45.40% | 27.48% |
| 31.50% | 24.25% | 18.45% | 24.07% | 45.62% | 35.65% | 37.08% | 35.81% | 27.65% | 17.44% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 25 | 47 | 46 | 38 | 56 | 70 | 63 | 53 | 48 | 71 |
| Inventory Days | 4 | 5 | 5 | 4 | 14 | 24 | 28 | 32 | 19 | 10 |
| Payable Days | 0 | 2000 | 1309 | 2104 | 215 | 132 | 115 | 114 | 99 | 193 |
| 30 | -1949 | -1259 | -2062 | -146 | -38 | -24 | -29 | -32 | -112 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.86x | 0.49x | 0.05x | 0.32x | 0.19x | 0.04x | 0.00x | 0.00x | 0.00x | 0.12x |
| Interest Coverage (x) | 13.26x | 12.96x | 12.59x | 52.71x | 34.85x | 42.66x | 72.31x | 440.64x | 347.14x | 181.05x |
| 0.34x | 0.69x | 0.99x | 0.63x | 1.49x | 2.84x | 2.93x | 2.30x | 1.87x | 1.84x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 3.77% | 9.40% | 8.71% | 5.80% | 107.37% | 6.39% | 26.82% | 29.19% | 14.45% | -11.20% |
| Operating Profit Growth % | -2.38% | 3.34% | -0.13% | 49.51% | 250.30% | 29.97% | 42.43% | 29.18% | 3.59% | -14.23% |
| Net Profit Growth % | 0.77% | -5.44% | -11.66% | 65.73% | 269.40% | 27.48% | 44.55% | 32.88% | 2.06% | -17.56% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -79.59% | -45.04% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 32.42x | 62.89x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 14.29x | 12.35x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.25% | 0.24% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 34.53x | 43.28x |
Mar 2016
- EPS (₹)
- 3.19
- Book Value (₹)
- 2.65
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.53
- Operating Margin %
- 19.02%
- Net Margin %
- 14.19%
- ROE %
- 302.71%
- ROCE %
- 80.38%
- 31.50%
- Debtor Days
- 25
- Inventory Days
- 4
- Payable Days
- 0
- 30
- Debt to Equity (x)
- 0.86x
- Interest Coverage (x)
- 13.26x
- 0.34x
- Revenue Growth %
- 3.77%
- Operating Profit Growth %
- -2.38%
- Net Profit Growth %
- 0.77%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 3.01
- Book Value (₹)
- 5.65
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.50
- Operating Margin %
- 17.97%
- Net Margin %
- 12.26%
- ROE %
- 72.63%
- ROCE %
- 54.67%
- 24.25%
- Debtor Days
- 47
- Inventory Days
- 5
- Payable Days
- 2000
- -1949
- Debt to Equity (x)
- 0.49x
- Interest Coverage (x)
- 12.96x
- 0.69x
- Revenue Growth %
- 9.40%
- Operating Profit Growth %
- 3.34%
- Net Profit Growth %
- -5.44%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 2.66
- Book Value (₹)
- 8.34
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.46
- Operating Margin %
- 16.51%
- Net Margin %
- 9.97%
- ROE %
- 38.06%
- ROCE %
- 42.22%
- 18.45%
- Debtor Days
- 46
- Inventory Days
- 5
- Payable Days
- 1309
- -1259
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 12.59x
- 0.99x
- Revenue Growth %
- 8.71%
- Operating Profit Growth %
- -0.13%
- Net Profit Growth %
- -11.66%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 4.41
- Book Value (₹)
- 12.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.70
- Operating Margin %
- 23.33%
- Net Margin %
- 15.61%
- ROE %
- 41.85%
- ROCE %
- 44.88%
- 24.07%
- Debtor Days
- 38
- Inventory Days
- 4
- Payable Days
- 2104
- -2062
- Debt to Equity (x)
- 0.32x
- Interest Coverage (x)
- 52.71x
- 0.63x
- Revenue Growth %
- 5.80%
- Operating Profit Growth %
- 49.51%
- Net Profit Growth %
- 65.73%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 16.30
- Book Value (₹)
- 29.04
- Dividend per Share (₹)
- 1.65
- Cash EPS (₹)
- 2.30
- Operating Margin %
- 39.40%
- Net Margin %
- 27.81%
- ROE %
- 77.99%
- ROCE %
- 85.96%
- 45.62%
- Debtor Days
- 56
- Inventory Days
- 14
- Payable Days
- 215
- -146
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 34.85x
- 1.49x
- Revenue Growth %
- 107.37%
- Operating Profit Growth %
- 250.30%
- Net Profit Growth %
- 269.40%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 20.77
- Book Value (₹)
- 48.14
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.93
- Operating Margin %
- 48.14%
- Net Margin %
- 33.32%
- ROE %
- 53.82%
- ROCE %
- 67.89%
- 35.65%
- Debtor Days
- 70
- Inventory Days
- 24
- Payable Days
- 132
- -38
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 42.66x
- 2.84x
- Revenue Growth %
- 6.39%
- Operating Profit Growth %
- 29.97%
- Net Profit Growth %
- 27.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 30.03
- Book Value (₹)
- 71.11
- Dividend per Share (₹)
- 11.00
- Cash EPS (₹)
- 4.21
- Operating Margin %
- 54.06%
- Net Margin %
- 37.98%
- ROE %
- 50.35%
- ROCE %
- 67.91%
- 37.08%
- Debtor Days
- 63
- Inventory Days
- 28
- Payable Days
- 115
- -24
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 72.31x
- 2.93x
- Revenue Growth %
- 26.82%
- Operating Profit Growth %
- 42.43%
- Net Profit Growth %
- 44.55%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 39.90
- Book Value (₹)
- 102.66
- Dividend per Share (₹)
- 5.40
- Cash EPS (₹)
- 5.56
- Operating Margin %
- 54.06%
- Net Margin %
- 39.07%
- ROE %
- 45.92%
- ROCE %
- 61.51%
- 35.81%
- Debtor Days
- 53
- Inventory Days
- 32
- Payable Days
- 114
- -29
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 440.64x
- 2.30x
- Revenue Growth %
- 29.19%
- Operating Profit Growth %
- 29.18%
- Net Profit Growth %
- 32.88%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 8.14
- Book Value (₹)
- 27.72
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 5.75
- Operating Margin %
- 46.36%
- Net Margin %
- 34.84%
- ROE %
- 33.76%
- ROCE %
- 45.40%
- 27.65%
- Debtor Days
- 48
- Inventory Days
- 19
- Payable Days
- 99
- -32
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 347.14x
- 1.87x
- Revenue Growth %
- 14.45%
- Operating Profit Growth %
- 3.59%
- Net Profit Growth %
- 2.06%
- -79.59%
- P/E (x)
- 32.42x
- P/B (x)
- 14.29x
- Dividend Yield %
- 0.25%
- 34.53x
Mar 2025
- EPS (₹)
- 4.48
- Book Value (₹)
- 22.79
- Dividend per Share (₹)
- 0.67
- Cash EPS (₹)
- 4.97
- Operating Margin %
- 45.65%
- Net Margin %
- 32.34%
- ROE %
- 21.69%
- ROCE %
- 27.48%
- 17.44%
- Debtor Days
- 71
- Inventory Days
- 10
- Payable Days
- 193
- -112
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 181.05x
- 1.84x
- Revenue Growth %
- -11.20%
- Operating Profit Growth %
- -14.23%
- Net Profit Growth %
- -17.56%
- -45.04%
- P/E (x)
- 62.89x
- P/B (x)
- 12.35x
- Dividend Yield %
- 0.24%
- 43.28x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-14 - Gujarat Themis Biosyn Limited has informed the Exchange about Presentation and Transcript
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-10 - Gujarat Themis Biosyn Limited has informed the Exchange about Link of Recording
Annual Reports
Credit Ratings
- Credit Rating- Revision
2026-07-20 - Gujarat Themis Biosyn Limited has informed the Exchange about Credit Rating- Revision
- Credit Rating- Revision
2026-07-17 - Gujarat Themis Biosyn Limited has informed the Exchange about Credit Rating- Revision
Concalls
Aug 2026
Jun 2026
May 2026